Skip to main content

Table 2 Surgical data

From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome

Type of exenteration [n (%)]
 Total 15 (65)
 Anterior 5 (22)
 Posterior 3 (13)
Subtype of exenteration [n (%)]
 Type I (supralevator) 5 (22)
 Type II (infralevator) 8 (35)
 Type III (with vulvectomy) 10 (43)
Operative time (min) [Mean ± SD (range)] 439 ± 116 (210–690)
Subtype of reconstructive surgery [n (%)]
 Primary closure 13 (57)
 e-VRAM 7 (30)
 Neo-vagina 4 (17)
 Omentoplasty 10 (43)
 Gracilis flap 1 (4)
 V-Y flap 2 (9)
Ostomy [n (%)]
 No 5 (22)
 Colostomy 18 (78)
Urinary derivation [n (%)]
 No 3 (13)
 Bricker 19 (83)
 Nephrostomy 1 (4)
Lymph node dissection [n (%)]
 No 9 (40)
 Inguinal 4 (17)
 Pelvic 7 (30)
 Paraortic 6 (26)
Other procedures [n (%)]
 Pubic bone resection 2 (9)
 Mesh wall repair 4 (17)
Intraoperative complications [n (%)] 1 (4)
Red blood units transfusion [Mean ± SD (range)] 0.96  ± 1.15 (0–5)
Estimated blood loss (ml) [Mean ± SD (range)] 612 ± 320 (300–1300)
Margin status [n (%)]
 R0 21 (91)
R < 1 2 (9)